Literature DB >> 11171837

Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease.

G Monteleone1, S L Pender, E Alstead, A C Hauer, P Lionetti, C McKenzie, T T MacDonald.   

Abstract

Coeliac disease (CD) is caused by a CD4 T helper cell type 1 (Th1) response in the small intestinal mucosa to dietary gluten. As the major Th1 inducing cytokine, interleukin 12, is undetectable in CD gut mucosa, the mechanism by which Th1 effector cells are generated remains unknown. Interferon (IFN) alpha, a cytokine capable of promoting IFN-gamma synthesis, has been implicated in the development of Th1 mediated immune diseases. Here we report a case of CD-like enteropathy in a patient receiving IFN-alpha for chronic myeloid leukaemia. Morphological assessment of duodenal biopsies taken from the patient showed total villous atrophy, crypt cell hyperplasia, and a high number of CD3+ intraepithelial lymphocytes. Both antigliadin antibodies and antiendomysial antibodies were positive. RNA analysis revealed pronounced expression of IFN-gamma. Withdrawal of gluten from the diet resulted in a patchy improvement in intestinal morphology, normalisation of laboratory parameters, and resolution of clinical symptoms. By western blot analysis, IFN-alpha protein was seen in the duodenal mucosa from untreated CD patients but not in controls. This was associated with marked expression of IFN-gamma protein in CD mucosa. Collectively, these results suggest a role for IFN-alpha in promoting Th1 responses to gluten.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171837      PMCID: PMC1760133          DOI: 10.1136/gut.48.3.425

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

Review 1.  Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease.

Authors:  P C Dubois; D A van Heel
Journal:  Clin Exp Immunol       Date:  2008-08       Impact factor: 4.330

Review 2.  Tissue-mediated control of immunopathology in coeliac disease.

Authors:  Bana Jabri; Ludvig M Sollid
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

Review 3.  Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow.

Authors:  Giovanna Vitaliti; Andrea Domenico Praticò; Carla Cimino; Giovanna Di Dio; Elena Lionetti; Mario La Rosa; Salvatore Leonardi
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 4.  Interferon alpha: The key trigger of type 1 diabetes.

Authors:  Angela Lombardi; Effie Tsomos; Sara S Hammerstad; Yaron Tomer
Journal:  J Autoimmun       Date:  2018-08-14       Impact factor: 7.094

Review 5.  Innate immunity: actuating the gears of celiac disease pathogenesis.

Authors:  Sangman Michael Kim; Toufic Mayassi; Bana Jabri
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-05-11       Impact factor: 3.043

6.  In the Intestinal Mucosa of Children With Potential Celiac Disease IL-21 and IL-17A are Less Expressed than in the Active Disease.

Authors:  Melissa Borrelli; Carmen Gianfrani; Giuliana Lania; Rosita Aitoro; Katia Ferrara; Merlin Nanayakkara; Domenico Ponticelli; Delia Zanzi; Valentina Discepolo; Serena Vitale; Maria Vittoria Barone; Riccardo Troncone; Renata Auricchio; Mariantonia Maglio
Journal:  Am J Gastroenterol       Date:  2016-01-12       Impact factor: 10.864

Review 7.  Triggers and drivers of autoimmunity: lessons from coeliac disease.

Authors:  Ludvig M Sollid; Bana Jabri
Journal:  Nat Rev Immunol       Date:  2013-03-15       Impact factor: 53.106

8.  Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa.

Authors:  I Monteleone; G Monteleone; G Del Vecchio Blanco; P Vavassori; S Cucchiara; T T MacDonald; F Pallone
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 9.  Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease.

Authors:  Daniela De Nitto; Ivan Monteleone; Eleonora Franzè; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

10.  Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients.

Authors:  Marcela Medina; Giada De Palma; Carmen Ribes-Koninckx; Miguel Calabuig; Yolanda Sanz
Journal:  J Inflamm (Lond)       Date:  2008-11-03       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.